[1] | Haiyang ZHU, Jingshu CUI, Liu YANG, Mengting ZHOU, Jian TONG, Hongmei HAN. Mechanism of 1,25(OH)2D3 improving liver inflammation in a rat model of nonalcoholic steatohepatitis induced by choline-deficient L-amino acid-defined diet[J]. Journal of Clinical Hepatology, 2025, 41(2): 254-262. doi: 10.12449/JCH250210 |
[2] | Jingyi ZHANG, Yingmei TANG, Xian YANG, Wenxia YANG. Value of urinary α1-microglobulin and N-acetyl-β-D-glucosaminidase/urinary creatinine in monitoring early renal injury in patients with chronic hepatitis B virus-related liver diseases[J]. Journal of Clinical Hepatology, 2022, 38(2): 322-327. doi: 10.3969/j.issn.1001-5256.2022.02.014 |
[3] | Ha FuShuang, Han Tao, Liang Ning, Nie XinHua, Zhu ZhengYan. Effect of recombinant human granulocyte colony-stimulating factor on rats with acute liver failure[J]. Journal of Clinical Hepatology, 2019, 35(7): 1565-1569. doi: 10.3969/j.issn.1001-5256.2019.07.028 |
[4] | Pang XiangJun, Zhao Na, Wang ShouQing, Xin GuiJie. Intractable hypokalemia caused by glycyrrhizinic acid preparations:a case report[J]. Journal of Clinical Hepatology, 2017, 33(7): 1344-1345. doi: 10.3969/j.issn.1001-5256.2017.07.030 |
[5] | Shi HongBo, Shi HongLin, Zhang XiangYing, Chen DeXi, Duan ZhongPing, Ren Feng. Protective effect of autophagy in mice with acute liver injury induced by D- galactosamine / lipopolysaccharide and related mechanisms[J]. Journal of Clinical Hepatology, 2017, 33(2): 329-333. doi: 10.3969/j.issn.1001-5256.2017.02.027 |
[6] | Expert Committee on Clinical Application of Glycyrrhizin Preparation in the Treatment of Liver Diseases. Expert consensus on clinical application of glycyrrhizin preparation in the treatment of liver diseases[J]. Journal of Clinical Hepatology, 2016, 32(5): 844-852. doi: 10.3969/j.issn.1001-5256.2016.05.004 |
[7] | Pan Kai, Zhao Qiang, Tao YanYan, Chen GaoFeng, Liu ChengHai. Efficacy of Jiawei Jianpi Bushen prescription in treatment of liver fibrosis and its role in regulating Treg/Th17 balance[J]. Journal of Clinical Hepatology, 2016, 32(8): 1518-1524. doi: 10.3969/j.issn.1001-5256.2016.08.017 |
[8] | Li XiaoPeng, Li Ming, Lei Wan, Zhang LunLi. Protective effect of magnesium isoglycyrrhizinate in rats with acute liver failure induced by D- galactosamine[J]. Journal of Clinical Hepatology, 2016, 32(3): 545-548. doi: 10.3969/j.issn.1001-5256.2016.03.032 |
[9] | Ye Chao, Chen YongPing, Dai ZhiJuan, Li WenYuan, Lin Zhuo, Cheng Yuan, Jin XiaoZhi. Dynamic expression of β-catenin in rat models of hepatic fibrosis and its significance[J]. Journal of Clinical Hepatology, 2011, 27(3): 261-264. |
[10] | Sun LinLin, Shi Jun, Hao JingHua, Ren WanHua, Yan ChunYing, Zhang Jie, Lin XiaoYan, Cui Bin. Effect of high-fat diet on establishment of a rat non-alcoholic steatohepatitis/liver fibrosis model[J]. Journal of Clinical Hepatology, 2011, 27(3): 254-257+272. |
[11] | Li YaPing, Dang ShuangSuo, Zhai Song, Jia XiaoLi, Wang Yuan, Wang XiuFang, Wang WenJun, Li Mei. Immunohistochemical expression of NF-κB, α-SMA and TGFβ1 in experimental hepatic injury rats[J]. Journal of Clinical Hepatology, 2011, 27(11): 1207-1210. |
[12] | Li TieHan, Tang Bo, Tang JiHong, Fu BiMang, Zhu Hong, Zhang Jie. Expression of heme oxygenase in the kidney of experimental cirrhotic rat[J]. Journal of Clinical Hepatology, 2011, 27(3): 265-267. |
[14] | Yin HeKun, Li QiXiang, Luo Dan. The clinical study of L-ornithine-L-aspartate combined with SNMC for hepatic encephalopathy of liver cirrhosis[J]. Journal of Clinical Hepatology, 2007, 23(4): 268-269. |
[15] | Wang JiPing, Leng JiYan, Dong Dong, Yan WeiQun. The protective effect of rhKD/APP on liver injured by D-galactosamine in rats[J]. Journal of Clinical Hepatology, 2007, 23(1): 24-25. |